Australia's TGA reviews guidance on over-the-counter medicines
This article was originally published in SRA
Australia’s Therapeutic Goods Administration has begun a project to review and amend the guidelines for over-the-counter medicines so they reflect the present regulatory environment and business practices for these products1.
You may also be interested in...
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.